Glyco-binding domain chimeric antigen receptors as a new option for cancer immunotherapy

In the last decade, treatment using Chimeric Antigen Receptor (CAR) are largely studied and demonstrate the potential of immunotherapeutic strategies, as seen mainly for blood related cancers. Still, efficient CAR-T cell approaches especially for the treatment of solid tumors are needed. Tn- and Sia...

Descripción completa

Detalles Bibliográficos
Autores principales: Franke, Anna-Katharina, Wessolowski, Charlotte, Thaden, Vanessa, Müller, Ingo, Cornils, Kerstin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457195/
https://www.ncbi.nlm.nih.gov/pubmed/36529796
http://dx.doi.org/10.1038/s41434-022-00374-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457195/
https://www.ncbi.nlm.nih.gov/pubmed/36529796
http://dx.doi.org/10.1038/s41434-022-00374-x

Ejemplares similares